Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

398 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial.
Mahaffey KW, Held C, Wojdyla DM, James SK, Katus HA, Husted S, Steg PG, Cannon CP, Becker RC, Storey RF, Khurmi NS, Nicolau JC, Yu CM, Ardissino D, Budaj A, Morais J, Montgomery D, Himmelmann A, Harrington RA, Wallentin L; PLATO Investigators. Mahaffey KW, et al. Among authors: storey rf. J Am Coll Cardiol. 2014 Apr 22;63(15):1493-9. doi: 10.1016/j.jacc.2014.01.038. Epub 2014 Feb 19. J Am Coll Cardiol. 2014. PMID: 24561148 Free article. Clinical Trial.
Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
Lindholm D, James SK, Bertilsson M, Becker RC, Cannon CP, Giannitsis E, Harrington RA, Himmelmann A, Kontny F, Siegbahn A, Steg PG, Storey RF, Velders MA, Weaver WD, Wallentin L; PLATO Investigators. Lindholm D, et al. Among authors: storey rf. Clin Chem. 2017 Feb;63(2):573-584. doi: 10.1373/clinchem.2016.261271. Epub 2016 Dec 8. Clin Chem. 2017. PMID: 27932413 Clinical Trial.
Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome.
Lowenstern A, Storey RF, Neely M, Sun JL, Angiolillo DJ, Cannon CP, Himmelmann A, Huber K, James SK, Katus HA, Morais J, Siegbahn A, Steg PG, Wallentin L, Becker RC; PLATO Investigators. Lowenstern A, et al. Among authors: storey rf. J Thromb Thrombolysis. 2017 Aug;44(2):145-153. doi: 10.1007/s11239-017-1516-y. J Thromb Thrombolysis. 2017. PMID: 28608165 Free PMC article. Clinical Trial.
Ischaemic Events and Stent Thrombosis following Planned Discontinuation of Study Treatment with Ticagrelor or Clopidogrel in the PLATO Study.
Storey RF, Ardissino D, Vignali L, Cairns R, Becker RC, Cannon CP, Mahaffey KW, Himmelmann A, Katus HA, James SK, Wallentin L; PLATO Investigators. Storey RF, et al. Thromb Haemost. 2018 Feb;118(2):427-429. doi: 10.1160/TH17-05-0355. Epub 2018 Jan 29. Thromb Haemost. 2018. PMID: 29443375 Clinical Trial. No abstract available.
Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study.
Parker WAE, Eriksson N, Becker RC, Voora D, Åkerblom A, Himmelmann A, James SK, Wallentin L, Storey RF; PLATO Investigators. Parker WAE, et al. Among authors: storey rf. Platelets. 2019;30(5):579-588. doi: 10.1080/09537104.2018.1478404. Epub 2018 May 31. Platelets. 2019. PMID: 29851527
Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy.
Nelson TA, Parker WAE, Ghukasyan Lakic T, Westerbergh J, James SK, Siegbahn A, Becker RC, Himmelmann A, Wallentin L, Storey RF. Nelson TA, et al. Among authors: storey rf. Platelets. 2022 Apr 3;33(3):425-431. doi: 10.1080/09537104.2021.1934667. Epub 2021 Jun 2. Platelets. 2022. PMID: 34077291 Clinical Trial.
398 results